ArticleFrontiers in pharmacology2022

Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma.

Yingpinyapat Kittirat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.